Clinical outcome and gene- and microRNA-expression profiling according to the Wilms tumor 1 (WT1) single nucleotide polymorphism rs16754 in adult de novo cytogenetically normal acute myeloid leukemia: a Cancer and Leukemia Group B study
      QxMD      Google Scholar   
Citation:
Haematologica vol 96 (10) 1488-95
Year:
2011
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
1
Parents:
376  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, P50 CA140158, CA140158, CA16058, CA101140, U10 CA077658, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, P30 CA016058, CA77658, CA129657, CA114725, CA31946  
Corr. Author:
 
Authors:
                                         
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8525, CALGB-10201, CALGB-19808, CALGB-20202, CALGB-20502, CALGB-8461, CALGB-8923, CALGB-9420, CALGB-9621, CALGB-9665, CALGB-9720
Phases:
1, 3, N/A
Keywords:
rs16754, SNP, outcome, WT1 , acute myeloid leukemia